Remix Therapeutics is developing small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.
Location: United States, Massachusetts, Cambridge
Total raised: $211M
Investors 3
| Date | Name | Website |
| - | Foresite C... | foresiteca... |
| 26.03.2022 | ARCH Ventu... | archventur... |
| - | Atlas Vent... | atlasventu... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 03.01.2024 | - | $60M | - |
| 18.05.2022 | Series B | $70M | Foresite C... |
| 08.12.2020 | Series A | $81M | - |
Mentions in press and media 15
| Date | Title | Description | Source |
| 03.01.2024 | Remix Therapeutics Closes $60M Financing | Remix Therapeutics, a Cambridge, MA-based clinical-stage biotechnology company developing small mole... | finsmes.co... |
| 09.01.2023 | Healthcare Hires of Note | ProofPilot, a digital protocol automation platform for clinical trials, has added Bernadette Tosti t... | medcitynew... |
| 18.05.2022 | Remix Therapeutics reels in $70M Series B | Remix Therapeutics has raised $70 million from investors including Surveyor, Foresite Capital and Ar... | pitchbook.... |
| 18.05.2022 | Remix Therapeutics Raises $70 Million in Series B Financing | Remix Therapeutics, a Cambridge, MA-based biotechnology company developing small molecule therapies ... | finsmes.co... |
| 17.05.2022 | Remix closes $70M funding with pipeline 'really humming,' bu... | RNA-focused Remix Therapeutics has wrapped up a $70 million series B, bringing its total fundraising... | fiercebiot... |
| 17.02.2022 | J&J partners with startup Remix, aiming to treat disease... | Much drug research has focused on small molecules that target disease-causing proteins. However, the... | medcitynew... |
| 09.12.2020 | Remix Therapeutics launches with $81M Series A | Remix Therapeutics has raised $81 million in a round led by Foresite Capital, with participation fro... | pitchbook.... |
| 08.12.2020 | Remix Therapeutics Launches with $81 Million Financing to De... | CAMBRIDGE, Mass., Dec. 8, 2020 /PRNewswire/ -- Remix Therapeutics, a biotechnology company develop... | prnewswire... |
| 08.12.2020 | The Briefing: Calm Hits $2B Valuation With New Round, Dragos... | 8 Shares Email Facebook Twitter LinkedIn Here’s what you need to know today in startup and venture ... | news.crunc... |
| 08.12.2020 | The Briefing: Calm Hits $2B Valuation With New Round, Dragos... | 7 Shares Email Facebook Twitter LinkedIn Here’s what you need to know today in startup and venture ... | news.crunc... |
Show more